GL1X · GenesisL1 explorer

MolNFT v1 · #378221 · protein

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (A7MGV3)

A7MGV3: “AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (A7MGV3)”. 4 pockets (best druggability 0.83). MolNFT v1 #378221 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
A7MGV3
Type
protein
Length
388 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x6210d44A4915BD5e50Be1f4196Df3F7d8ebD63e8
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
A7MGV3
Pockets
4 · best druggability 0.83

Structure

1 distinct chain · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein38838% helix, 18% strandA7MGV3

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11930.830.9732empty
23500.650.8038empty
31120.410.7624empty
4710.330.7616empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.